The Zepbound out-of-pocket cost is one of the biggest concerns for patients considering this weight loss medication. Zepbound (tirzepatide), manufactured by Eli Lilly, has shown remarkable clinical results for weight management, but its price tag presents a significant barrier for many Americans. Understanding the Zepbound out-of-pocket cost across different insurance scenarios, savings programs, and alternative pathways is essential for making this medication financially sustainable.
Zepbound received FDA approval for chronic weight management in November 2023 and has quickly become one of the most prescribed weight loss medications in the country. Clinical trials published in the New England Journal of Medicine demonstrated average weight loss of 18 to 22.5 percent of body weight, making tirzepatide one of the most effective anti-obesity medications ever studied. But effectiveness means little if patients cannot afford the treatment.
This guide breaks down exactly what Zepbound costs with and without insurance, how to access savings programs, and what alternatives exist if the price is out of reach. For a broader look at healthcare pricing, see our costs guide.
Zepbound List Price and Retail Cost
Understanding the baseline pricing structure is the first step in estimating your personal out-of-pocket cost.
List price. Eli Lilly has set the list price of Zepbound at approximately $1,059.87 per month for a four-week supply (four single-dose pens). This price applies regardless of the dose, whether you are on the starting dose of 2.5 mg or the maximum dose of 15 mg.
Retail pharmacy cost. Without insurance and without any discounts, the cash price at retail pharmacies typically ranges from $1,000 to $1,300 per month. Prices can vary by pharmacy, with independent pharmacies sometimes offering lower prices than chain pharmacies. Specialty pharmacies may also have different pricing structures.
Annual cost without insurance. At full list price, a year of Zepbound treatment costs approximately $12,700 to $15,600. For a medication that current evidence suggests needs to be taken long-term to maintain weight loss, this represents a substantial ongoing financial commitment.
These numbers can be intimidating, but very few patients pay the full list price. Insurance coverage, manufacturer savings programs, and alternative purchasing strategies can reduce the cost dramatically. The next sections explain each pathway.
Zepbound Cost With Commercial Insurance
If you have employer-sponsored or marketplace health insurance, your out-of-pocket cost for Zepbound depends entirely on your plan’s formulary coverage and benefit design.
Plans that cover Zepbound. A growing number of commercial insurance plans have added Zepbound to their formularies, though it is typically classified as a specialty or non-preferred brand medication with higher cost-sharing. If your plan covers Zepbound, your costs may look like this:
Preferred brand copay: $50 to $150 per month. Specialty tier copay or coinsurance: $100 to $500 per month, depending on whether the plan uses a flat copay or a percentage-based coinsurance. Plans with 25 to 33 percent coinsurance on specialty medications would result in monthly costs of $250 to $350 before any manufacturer discounts.
Plans that do not cover Zepbound. Many insurance plans still exclude anti-obesity medications from their formularies entirely. If your plan does not cover Zepbound, you face the full retail price unless you can access a savings program or alternative pathway. The Kaiser Family Foundation reports that coverage for weight loss medications remains inconsistent across commercial insurance plans, though coverage is trending upward.
Prior authorization. Even when covered, Zepbound almost always requires prior authorization. Your prescribing physician must document that you meet specific criteria, typically a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity, and that you have attempted lifestyle modifications. The prior authorization process can take several days to weeks. Your provider or pharmacist can help navigate this process.
Step therapy requirements. Some plans require patients to try and fail a less expensive weight loss medication before approving Zepbound. This is known as step therapy. Common step therapy requirements include trying medications like phentermine, orlistat, or naltrexone-bupropion before Zepbound is approved.
Zepbound Cost With Medicare and Medicaid
Coverage through government programs has specific limitations that patients should understand.
Medicare Part D. As of early 2026, Medicare Part D does not cover medications prescribed solely for weight loss. This exclusion is based on a longstanding statutory prohibition on Medicare coverage of weight loss drugs. However, if Zepbound is prescribed for type 2 diabetes management (off-label, as it is marketed as Mounjaro for this indication), Medicare may cover it under the diabetes formulary. CMS has been considering policy changes regarding anti-obesity medication coverage, and this is an evolving area.
Medicaid. Medicaid coverage for Zepbound varies by state. Some state Medicaid programs cover anti-obesity medications, while others exclude them. Even in states with coverage, prior authorization and step therapy requirements are common. Contact your state Medicaid agency or managed care plan to verify coverage.
VA and military insurance. The Department of Veterans Affairs and TRICARE have varying policies on anti-obesity medication coverage. TRICARE has covered some GLP-1 medications for weight management, though formulary placement and prior authorization requirements apply. VA coverage depends on the individual facility and clinical criteria.
Eli Lilly Savings Programs and Discounts
Eli Lilly offers several programs designed to reduce the out-of-pocket cost of Zepbound for eligible patients.
Zepbound Savings Card. Commercially insured patients whose plans cover Zepbound may be eligible for a manufacturer savings card that reduces their copay to as low as $25 per month. The savings card covers the difference between your insurance copay and $25, up to a maximum benefit per fill. This program is not available to patients with government insurance (Medicare, Medicaid, TRICARE) or those whose plans do not cover Zepbound.
LillyDirect. Eli Lilly launched LillyDirect, a direct-to-patient platform that offers Zepbound at specific pricing tiers. Through LillyDirect, patients without insurance coverage for Zepbound can access the medication at a reduced self-pay price. Check the LillyDirect website for current pricing and eligibility requirements.
Patient assistance programs. Eli Lilly offers patient assistance programs for uninsured and underinsured patients who meet income eligibility criteria. These programs may provide Zepbound at no cost or significantly reduced cost. Eligibility is typically based on household income relative to the federal poverty level.
It is important to re-verify savings program availability and terms periodically, as pharmaceutical companies frequently update their programs. For information on getting Zepbound prescribed online, see our guide to Zepbound online prescriptions.
Alternative Ways to Reduce Zepbound Costs
Beyond manufacturer programs, several strategies can help reduce your out-of-pocket cost.
Pharmacy discount programs. GoodRx, RxSaver, and similar discount tools aggregate pricing across pharmacies and may offer coupons that reduce the cash price. While the discounts on brand-name specialty medications like Zepbound are typically modest compared to generics, they are worth checking.
Compounded tirzepatide. Some compounding pharmacies produce tirzepatide at lower prices than brand-name Zepbound. Compounded versions are available when the brand-name drug is on the FDA’s drug shortage list. Prices for compounded tirzepatide typically range from $200 to $500 per month. However, compounded medications are not FDA-approved, and quality can vary between compounding pharmacies. Discuss this option with your healthcare provider and verify that any compounding pharmacy is properly licensed and accredited.
Switching between formulations. If your insurance covers Mounjaro (the diabetes formulation of tirzepatide) but not Zepbound, and you have type 2 diabetes, your provider may be able to prescribe Mounjaro for blood sugar management, which also produces weight loss. This approach uses the same active ingredient with potentially better insurance coverage. For a comparison of similar medications, see our guide to Mounjaro costs without insurance.
Alternative GLP-1 medications. If Zepbound is not affordable, other GLP-1 medications may be covered by your insurance. Semaglutide (Wegovy) is the primary alternative for weight management, and some patients respond well to liraglutide (Saxenda). Each has different pricing and insurance coverage patterns. Our guide to semaglutide costs provides a detailed comparison.
HSA and FSA. If you have a Health Savings Account or Flexible Spending Account, Zepbound is an eligible medical expense. Paying with pre-tax dollars effectively reduces your cost by your marginal tax rate, potentially saving 22 to 37 percent depending on your tax bracket.
Is Zepbound Worth the Cost?
The value equation for Zepbound extends beyond the monthly prescription cost. Consider these factors when evaluating whether the investment is worthwhile.
Health benefits. The NIH has documented that a 10 to 15 percent reduction in body weight produces significant improvements in blood pressure, blood sugar, cholesterol, sleep apnea, and joint pain. The weight loss achieved with Zepbound exceeds these thresholds for most patients, potentially reducing or eliminating the need for medications treating these conditions.
Reduced future healthcare costs. Obesity is associated with significantly higher lifetime healthcare expenditures, according to CDC data. The cost of treating obesity-related conditions, including type 2 diabetes, cardiovascular disease, and certain cancers, can dwarf the cost of preventive pharmacotherapy.
Quality of life. Patients in clinical trials reported significant improvements in physical functioning, mobility, energy levels, and psychological well-being. These quality-of-life improvements are difficult to quantify financially but are meaningful to patients.
Long-term commitment. Current evidence suggests that weight regain occurs in most patients who discontinue GLP-1 medications. A study published in JAMA showed that patients who stopped tirzepatide regained a significant portion of their lost weight over the following year. This means the financial commitment may be ongoing, which makes affordable access even more important.
Frequently Asked Questions
What is the cheapest way to get Zepbound?
The cheapest legitimate pathway depends on your insurance situation. If your commercial insurance covers Zepbound, combining insurance coverage with the manufacturer savings card can reduce your cost to as low as $25 per month. Without insurance coverage, compounded tirzepatide through a licensed compounding pharmacy typically offers the lowest price, usually $200 to $500 per month. Eli Lilly’s patient assistance program may provide the medication at no cost for qualifying low-income patients.
Will Zepbound ever become generic?
Eli Lilly’s patents on tirzepatide extend for several more years, and generic versions are not expected in the near term. However, the pharmaceutical patent landscape is complex, and biosimilar or generic competition could eventually lower prices. In the meantime, compounded versions offer a lower-cost alternative, though with different regulatory oversight.
Can I get Zepbound through telehealth?
Yes. Multiple telehealth platforms prescribe Zepbound after conducting a medical evaluation. Telehealth can be a convenient way to access the medication, especially if your local physician is not familiar with prescribing it. See our guide to getting Zepbound online for platform recommendations and pricing details.
Does the cost of Zepbound vary by dose?
No. The list price of Zepbound is the same regardless of dose. Whether you are on the 2.5 mg starting dose or the 15 mg maximum dose, the cost per four-week supply remains approximately $1,059.87. This uniform pricing means there is no financial penalty for titrating up to a higher dose as recommended by your provider.
What if my insurance denies coverage for Zepbound?
If your insurance denies coverage, you have several options. First, appeal the denial. Your provider can submit additional clinical documentation supporting medical necessity. Many initial denials are overturned on appeal. Second, explore the manufacturer savings programs and patient assistance programs described above. Third, consider alternative GLP-1 medications that may be on your plan’s formulary. Fourth, discuss compounded tirzepatide with your provider as a lower-cost alternative.
Planning Your Path to Affordable Treatment
The Zepbound out-of-pocket cost is a significant consideration, but it should not be the sole factor in your treatment decision. Work with your healthcare provider and insurance company to explore every available option for reducing costs. Start by checking your insurance formulary, applying for manufacturer savings programs, and comparing pharmacy pricing. If the branded medication remains unaffordable, discuss compounded alternatives and other GLP-1 medications with your provider.
Weight management is a long-term health investment, and finding a sustainable financial path to treatment is just as important as the clinical decision to start medication. For more on navigating healthcare costs, explore our costs guide.